Page last updated: 2024-08-24

gemcitabine and flavokawain b

gemcitabine has been researched along with flavokawain b in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Eskander, RN; Guo, Y; Hoang, B; Randall, LM; Sakai, T; Zi, X	1

Other Studies

1 other study(ies) available for gemcitabine and flavokawain b

Article	Year
Flavokawain B, a novel, naturally occurring chalcone, exhibits robust apoptotic effects and induces G2/M arrest of a uterine leiomyosarcoma cell line. The journal of obstetrics and gynaecology research, 2012, Volume: 38, Issue:8 Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Deoxycytidine; Docetaxel; Drug Evaluation, Preclinical; Drug Synergism; Female; Fibroblasts; Flavonoids; G2 Phase Cell Cycle Checkpoints; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Apoptosis Proteins; Leiomyosarcoma; Phytotherapy; Plant Extracts; Survivin; Taxoids; Uterine Neoplasms	2012

Article

Year

Flavokawain B, a novel, naturally occurring chalcone, exhibits robust apoptotic effects and induces G2/M arrest of a uterine leiomyosarcoma cell line.

The journal of obstetrics and gynaecology research, 2012, Volume: 38, Issue:8

Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Deoxycytidine; Docetaxel; Drug Evaluation, Preclinical; Drug Synergism; Female; Fibroblasts; Flavonoids; G2 Phase Cell Cycle Checkpoints; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Apoptosis Proteins; Leiomyosarcoma; Phytotherapy; Plant Extracts; Survivin; Taxoids; Uterine Neoplasms

2012